D. Vijay Pharma Private Limited

Strength	11.25 mg
Brand	Dr. Reddy''s
Medicine Type	Allopathic
Composition	Triptorelin Powder for Injection
Prescription/Non prescription	Prescription
Packaging Type	Vial
Dose	11.25 mg

Triptorelin (Pamorelin) is administered as a single intramuscular (IM) injection; the 3.75 mg format may also be administered as a single subcutaneous (SC) injection. No dosage adjustment is necessary for patients with renal or hepatic impairment.

Triptorelin injection (Triptodur) is used to treat central precocious puberty (CPP; a condition causing children to enter puberty too soon, resulting in faster than normal bone growth and development of sexual characteristics) in children 2 years and older.

Additional Information:

• Item Code: 3558
• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),D/P
• Port of Dispatch: MUMBAI,NASHIK,INDIA
• Packaging Details: ROOM TEMPETATURE

Manufacturer	ELI LILY PHARMA
Brand	CYRAMZA INJECTION
Packaging Size	VIAL
Prescription/Non prescription	Prescription
Composition	RAMUCIRUMAB
Shelf life	12 MONTHS
Form	Injection

Cyramza (ramucirumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Cyramza is used to treat stomach cancer, colorectal cancer, or non-small cell lung cancer that has spread to other parts of the body, and hepatocellular carcinoma

Additional Information:

• Item Code: 2602
• Delivery Time: DEPEND ON LOCATION

Dose Strength	150MG
Composition	Fosaprepitant
Generic Name	FOSAPREPITANT
Brand	GLENMARK
Usage/Application	Hospital
Packaging Size	VIAL
Medicine Type	Injection
Type	Allopathic
Product Type	Finished Product
Gender	Unisex
Shelf Life	20 MONTHS

It is used after chemotherapy or after surgery to prevent vomiting and feelings of nausea. It functions by blocking the substances in the brain that cause nausea and vomiting. ... Avoid using this medication if you are allergic to any ingredient contained within Aprecap 150Mg Injection ..

Aprecap is used in adults in combination with other medicines to prevent nausea and vomiting caused by chemotherapy (cancer treatment) or in some cases after a surgery.

Additional Information:

• Item Code: 2217
• Delivery Time: DEPEND ON LOCATION

Packaging Size	VIAL
Manufacturer	NATCO PHARMA
Packaging	VIAL
Treatment	CANCER
Prescription/Non prescription	Prescription
Brand	Natco
Usage	Hospital
Dose	1.5 mg
Composition	Rasburicase

Other Details:

• For intravenous infusion
• One single use vial 
• One diluent vial

Below are the Comprtitor brands available with D.Vijay Pharma Pvt. Ltd. Kindly see the table file below.

Additional Information:

• Item Code: 10513
• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),D/P
• Port of Dispatch: Mumbai, Nashik , India
• Packaging Details: 2 to 8 Degrees cold chain product Below are the Competitor brands available with D.Vijay Pharma Pvt. Ltd. Kindly see the PDF file below.

Brand	Hetero
Composition	Plexrixafor
Injectable Form	Liquid
Dose	1.2ml
Packaging Size	Vial
Medicine Type	Injection
Product Type	Finished Product
Gender	Unisex
Packaging Type	Box
Power	1.2Ml Injection
Shelf Life	25 Months

Mozobil (plerixafor) injection is a sterile, preservative-free, clear, colorless to pale-yellow, isotonic solution for subcutaneous injection. Each mL of the sterile solution contains 20 mg of plerixafor. Each single-use vial is filled to deliver 1.2 mL of the sterile solution that contains 24 mg of plerixafor and 5.9 mg of sodium chloride in Water for Injection adjusted to a pH of 6.0 to 7.5 with hydrochloric acid and with sodium hydroxide, if required.

Plerixafor is a hematopoietic stem cell mobilizer with a chemical name l, 1’-[1,4phenylenebis(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane. It has the molecular formula C28H54N8. The molecular weight of plerixafor is 502.79 g/mol.

Mozobil®(plerixafor) injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM).

Recommended Dosage And Administration

Vials should be inspected visually for particulate matter and discoloration prior to administration and should not be used if there is particulate matter or if the solution is discolored.

Begin treatment with Mozobil after the patient has received G-CSF once daily for four days [see Recommended Concomitant Medications]. Administer Mozobil approximately 11 hours prior to initiation of each apheresis for up to 4 consecutive days.

The recommended dose of Mozobil by subcutaneous injection is based on body weight:

• 20 mg fixed dose or 0.24 mg/kg of body weight for patients weighing ≤83 kg. [see CLINICAL PHARMACOLOGY]
• 0.24 mg/kg of body weight for patients weighing >83 kg.

Use the patient’s actual body weight to calculate the volume of Mozobil to be administered. Each vial delivers 1.2 mL of 20 mg/mL solution, and the volume to be administered to patients should be calculated from the following equation:

0.012 × patient’s actual body weight (in kg) = volume to be administered (in mL)

In clinical studies, Mozobil dose has been calculated based on actual body weight in patients up to 175% of ideal body weight. Mozobil dose and treatment of patients weighing more than 175% of ideal body weight have not been investigated.

 

Based on increasing exposure with increasing body weight, the Mozobil dose should not exceed 40 mg/day.

Additional Information:

• Item Code: 16280
• Delivery Time: Depends on location

Packaging Size	vial
Brand	borviz 2.5mg injection
Composition	bortezomib
Manufacturer	Intas Pharmaceuticals
Prescription/Non prescription	Prescription
Form	Injection
Strength	2mg/2.5mgmg
Country of Origin	Made in India

Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system). Bortezomib is in a class of medications called antineoplastic agents.
This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells.